1. health and life sciences
Driving innovation in
health and life sciences
Dr Ian Campbell
Director, Health and Life Sciences
@IanWCampbell
15 minutes including questions
Ask who has heard of Innovate UK
Ask who has had Innovate UK funding

2. We can’t stop thinking about the future
Innovate UK – the UK’s innovation agency
We work with people, companies and partner organisations to find and drive the science and technology innovations that will grow the UK economy - delivering productivity, new jobs and exports.
Our aim at Innovate UK is to keep the UK globally competitive in the race for future prosperity.
We can’t stop thinking about the future
Innovate UK’s mission – growth, productivity, jobs, exports.

3. 11,000 projects
70,000 jobs created
And a return on investment of up to £7.30 for every £1 invested.
Cross cutting nature within Innovate UK
From health and life sciences themes
Across into high value manufacturing themes.

4. Sectors approach to supporting businesses
Emerging
and
Enabling
Health
and Life
Sciences
Infrastructure
Systems
Manufacturing
Materials
Open
Programme
We have simplified our offering into four sectors, of which health and life sciences is one, and an open programme which funds the best innovation regardless of the sector it comes from.
Each of these sectors has broad-themed competitions. You can find out latest range of competitions on our website – innovateuk.org
Our competitions schedule includes programmes run with partners – more details on our webpage

5. Economic / societal challenges
Health and Life Sciences
Economic / societal challenges
Market potential
Mechanisms
Global population growing by 2bn to 9.7bn by 2050
50% more food needed by 2030
Healthcare costs rising > GDP
Prevalence of chronic illness and diet related disease increasing
Sector
Market
Year
Pharmaceuticals
$1.7tn
2025
Healthcare IT
$202bn
Medical technology
$583bn
Food (retail)
$4.0tn
2016
Agriculture
$2.4tn
CR&D competitions
Catapults and Agri Centres
Biomedical Catalyst
AgriTech Catalyst
SBRI
Knowledge Transfer Partnerships
Priority themes
Partnerships
Place
BEIS, DH, OLS, DIT, Defra, DfID
Devolved Administrations
Research Councils
ABPI, BioIndustry Association
British In Vitro Diagnostics Association
Agricultural Levy Boards
Precision Medicine
Medicines Discovery
Advanced Therapies
Agricultural Productivity
Food Quality
Health and Life Sciences supports businesses across UK - map shows locations of sector funded project partners

6. Partnerships in health and life sciences
Innovate UK does not work alone
These are the many partners and co-funders that my team work with on a daily basis to deliver our programmes supporting UK businesses.
From working together with the research councils to drive the best science through to commericalisation
To working with government departments and business support organisations in the devolved nations to deliver some of the examples I will talk about today.

7. Supporting health and life science businesses around the UK
Heat map showing locations of Innovate UK project partners in the health and life science sector
This heat map shows the locations of project partners – researchers and businesses – that we have supported in the health and life science area.
There are concentrations in the big cities where businesses, universities and hospitals are based.
But there are also hot spots in rural areas with an agriculture focus.
Key message here – keep applying and seek support in raising the quality of applications to help with getting above the funding threshold.

8. Innovate UK in the East of England
Total Innovate UK grant and unique applicants 2010/11 – 2016/17
Over £231 million to 2000 business innovation projects*
GCGP £159m 1,228
South East £71m
Hertfordshire £44m
New Anglia £18m
*LEP areas overlap, affects totals.
Not the only measure of innovation activity
All Innovate UK grants inc. large projects Aug 2016

9. Innovate UK in the East of England
Beattie Passive
Scottow Enterprise Zone
Processors & Growers Research Organisation
Peterborough
Cambridge Nanotherm
Haverhill
Sphere Fluidics
Babraham Research Campus, Cambridge
Revolve Technologies
Brentwood
Puridify
Stevenage BioScience Catalyst
All Innovate UK grants inc. large projects Aug 2016

10. The government’s Industrial Strategy sets out to do just this.
Investing in science, research & innovation
Upgrading infrastructure
Improving procurement
Delivering affordable energy & clean growth
Driving growth across the whole country
Developing skills
Supporting businesses to
start & grow
Encouraging trade & inward investment
Cultivating world-leading sectors
Creating the right local institutions
Innovation doesn't just happen – it takes strategic coordination between business, government, researchers in academia and private sector investors.
The government’s Industrial Strategy sets out to do just this.
Innovation weaves throughout the strategy
It is clearly a big focus through pillar number 1 – science, research and innovation
But also through skills, growth across the whole country, supporting businesses to start and grow, trade and inward investment, creating the right local institutions (like our Catapult network) and making the UK the best place in the world to innovate in different industries
Areas relevant to AMR – most of them!

11. Industrial Strategy Challenge Fund
Investing in science, research and innovation We must become a more innovative economy and do more to commercialise our world leading science base to drive growth across the UK
Industrial Strategy Challenge Fund
Industry-led and powered by multi-disciplinary research and business academic collaboration
Develop UK industries that are fit for the future, driving progress in technologies where the UK can become a world-leader in research and commercialisation
Pillar 1 of the Industrial Strategy has seen a lot of interest since the Prime Minister’s announcement of the new Industrial Strategy Challenge Fund
The Chancellor announced £4.7 billion for this parliament for this Fund, reaching £2 billion a year in funding.
It will run across Innovate UK and across the Research Councils - through the new UK Research and Innovation structure set to launch in a year’s time.
This really is the future of innovation – industry-led and powered by multi-disciplinary research and business academic collaboration.
The Fund will bridge research, translation and business.
And it will be challenge-focused – bringing sectors together to focus on the big problems that we can better solve by working together, combining science and business expertise.

12. Industrial Strategy Challenge Fund
Medicines manufacturing technologies
Robots for a safer world
6 challenges have been announced within the Industrial Strategy Challenge Fund so far – shown here on this slide.
Accelerating patient access to new drugs and treatments through developing brand new medicine manufacturing technologies
Developing cutting-edge artificial intelligence and robotics systems that will operate in extreme and hazardous environments
Development, design and manufacture of batteries that will power the next generation of electric vehicles
Developing the next generation of AI and control systems need to ensure the UK is at the forefront of the driverless cars revolution
Developing the next generation of affordable light-weight composite materials for aerospace, automotive and other advanced manufacturing sectors
New satellite test facility supporting new launch technologies and the manufacturing and testing capabilities that will allow the UK to construct future satellites and deliver payloads into orbit
And to hit the ground running, we have funded 35 projects with £10 million in a first wave – making the most of high quality projects that we haven’t been able to fund from our existing budget.
Most relevant challenge so far is medicines manufacturing technology – say here what you can within purdah…
Batteries for clean and flexible energy storage
Self-driving vehicles
Manufacturing and materials of the future
Satellites and space technology

13. £197m Medicines manufacturing technologies over 4 years
The medicines manufacturing challenge seeks to develop technologies for the manufacture of medicines that will speed up patient access to new drugs and treatments.
This will build on the exporting strengths of the UK’s biopharmaceutical sector.
Delivering new medicines to patients takes time, and we need to speed this up.
Here we are talking about traditional medicines but also biologics, cell and gene therapies, and vaccines.
£197 million has been announced for this challenge across the next 4 years.
First stages are [Ian to add verbal comments he is comfortable saying].
Developing first-of-a-kind technologies for the manufacture of medicines that will speed up patient access to new drugs and treatments, building on the exporting strengths of the UK’s biopharmaceutical sector

14. ISCF: Digital Health Technology Catalyst
AIM: to speed up the development of new digital solutions to healthcare challenges and grow the industry.
Projects must focus on the feasibility or development of digital health or digitally-enabled medical technologies. These must have the potential to achieve one or more of the following:
improve patient outcomes
transform healthcare delivery
enable more efficient delivery of healthcare
Technologies may be designed to be used in both clinical/ non-clinical everyday settings.
Digital health is evolving at a rapid pace and this is having a profound impact on healthcare delivery. Digital health uses data and technology to:
- improve patient outcomes
- improve access to healthcare
- make more targeted and personalised health interventions
- transform service delivery
- deliver new treatments and translational medicine
As this is the first DHTC call, we have deliberately gone with a broad scope.

15. Digital Health Technology Catalyst
Feasibility
Industrial Research and Experimental Development
Total Project Costs
£50,000 to £75,000
£500,000 to £1m
Project Duration
Up to one year
1 to 3 years
Project Start Date
By February 1st 2018
Project Type
Single SME or collaboration
Collaboration
Project Lead
UK based SME
Application Process
Single written
Dates & Timelines
Competition opens: 31st July ‘17
Registration by: 4th Oct ‘17
Application by: 11th Oct ’17

16. Precision medicine: impacting through innovative technology
Precision Medicine Competition: Impacting through Innovative technology
Innovate UK will invest up to £6 million in innovation projects to support the development of precision medicine (PM) technologies.
Feasibility – for analysis and evaluation of a concept’s potential, identify the requirements and resources needed to develop the technology, and establish the prospects of success.
Research  and development - for research and development applications, to develop and trial precision medicine technologies.  Projects must look to advance precision medicine by guiding decision-making using one of the following approaches:
Developing tools to better integrate informatics and data.
Establishing precision medicine clinical trials.
Developing rapid diagnostics to inform better treatment decisions.

17. The UK’s innovation agency
Precision Medicine Competition: Impacting through Innovative technology
Feasibility projects :
can last up to 12 months and have total project costs of up to £100,000.
can be from a single SME or an SME working with other businesses or research organisations collaborative projects led by an SME
Collaborative research and development projects :
can last up to 24 months and have total project costs of between £1 million to £2 million.
be collaborative and include at least 2 grant-claiming organisations
be led by a UK based company or RTO of any size
In this competition we are not funding projects that: 
do not inform treatment decisions
focus on drug discovery, biomarker discover, diagnostic tests for treatments that are still in development, unless justified as a parallel development, such as a companion diagnostic

18. The UK’s innovation agency
Precision Medicine Competition: Impacting through Innovative technology
You must explain clearly how your proposed technology will advance precision medicine. All proposals must offer innovative precision medicine technologies that improve the decision-making process for patient treatment selection
Competition dates:
Opens: 11th September 2017
Application Deadline: 25th October 2017
Applicants notified: 1st February 2018

19. We can’t stop thinking about the future
Supporting UK businesses, researchers and clinicians across health and life sciences
We can’t stop thinking about the future